{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "BMP-2 inducible kinase", "benzofuran", "benzothiophene", "docking"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36080338", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "30"}], "Language": ["eng"], "ELocationID": ["5571", "10.3390/molecules27175571"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "17", "PubDate": {"Year": "2022", "Month": "Aug", "Day": "30"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations.", "Abstract": {"AbstractText": ["Bone morphogenetic proteins (BMPs) are growth factors that have a vital role in the production of bone, cartilage, ligaments, and tendons. Tumors' upregulation of bone morphogenetic proteins (BMPs) and their receptors are key features of cancer progression. Regulation of the BMP kinase system is a new promising strategy for the development of anti-cancer drugs. In this work, based on a careful literature study, a library of benzothiophene and benzofuran derivatives was subjected to different computational techniques to study the effect of chemical structure changes on the ability of these two scaffolds to target BMP-2 inducible kinase, and to reach promising candidates with proposed activity against BMP-2 inducible kinase. The results of screening against Lipinski's and Veber's Rules produced twenty-one outside eighty-four compounds having drug-like molecular nature. Computational ADMET studies favored ten compounds (<b>11, 26, 27, 29, 30, 31, 34, 35, 65</b>, and <b>72</b>) with good pharmacokinetic profile. Computational toxicity studies excluded compound <b>34</b> to elect nine compounds for molecular docking studies which displayed eight compounds (<b>26, 27, 29, 30, 31, 35, 65</b>, and <b>72</b>) as promising BMP-2 inducible kinase inhibitors. The nine fascinating compounds will be subjected to extensive screening against serine/threonine kinases to explore their potential against these critical proteins. These promising candidates based on benzothiophene and benzofuran scaffolds deserve further clinical investigation as BMP-2 kinase inhibitors for the treatment of cancer."]}, "AuthorList": [{"Identifier": ["0000-0003-1045-0163"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia."}], "LastName": "Belal", "ForeName": "Amany", "Initials": "A"}, {"Identifier": ["0000-0003-0893-6703"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Elkady", "ForeName": "Hazem", "Initials": "H"}, {"Identifier": ["0000-0002-8173-6073"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt."}], "LastName": "Al-Karmalawy", "ForeName": "Ahmed A", "Initials": "AA"}, {"Identifier": ["0000-0002-9752-602X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Deanship of Scientific Research, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Zoology Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt."}], "LastName": "Amin", "ForeName": "Ali H", "Initials": "AH"}, {"Identifier": ["0000-0002-9179-4373"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}, {"Identifier": [], "Affiliation": "Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah, Riyadh 13713, Saudi Arabia."}], "LastName": "Ghoneim", "ForeName": "Mohammed M", "Initials": "MM"}, {"Identifier": ["0000-0002-0814-1743"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, P.O. Box 71666, Riyadh 11597, Saudi Arabia."}], "LastName": "El-Sherbiny", "ForeName": "Mohamed", "Initials": "M"}, {"Identifier": ["0000-0002-2121-9269"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Dental Sciences, College of Dentistry, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia."}], "LastName": "Al-Serwi", "ForeName": "Rasha Hamed", "Initials": "RH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Orthopedic Surgery Department, Al Iman General Hospital, Riyadh 11671, Saudi Arabia."}], "LastName": "Abdou", "ForeName": "Mohamed Attia", "Initials": "MA"}, {"Identifier": ["0000-0002-8235-5715"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Ibrahim", "ForeName": "Mona H", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zoology Department, Faculty of Science (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Mehany", "ForeName": "Ahmed B M", "Initials": "ABM"}], "GrantList": [{"GrantID": "22UQU4331100DSR14", "Agency": "Umm al-Qura University", "Country": ""}, {"GrantID": "MA-006", "Agency": "AlMaarefa University", "Country": ""}, {"GrantID": "PNURSP2022R199", "Agency": "Princess Nourah bint Abdulrahman University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Benzofurans"}, {"RegistryNumber": "0", "NameOfSubstance": "Bone Morphogenetic Protein 2"}, {"RegistryNumber": "0", "NameOfSubstance": "Bone Morphogenetic Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Protein Serine-Threonine Kinases"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Benzofurans"}, {"QualifierName": [], "DescriptorName": "Bone Morphogenetic Protein 2"}, {"QualifierName": ["metabolism"], "DescriptorName": "Bone Morphogenetic Proteins"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Protein Serine-Threonine Kinases"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Xiao Y.T., Xiang L.X., Shao J.Z. Bone morphogenetic protein. Biochem. Biophys. Res. Commun. 2007;362:550\u2013553. doi: 10.1016/j.bbrc.2007.08.045.", "ArticleIdList": ["10.1016/j.bbrc.2007.08.045", "17719560"]}, {"Citation": "Reddi A.H. Bone Morphogenetic Proteins: From Basic Science to Clinical Applications. J. Bone Jt. Surg. 2001;83:S1\u2013S6. doi: 10.2106/00004623-200100001-00001.", "ArticleIdList": ["10.2106/00004623-200100001-00001", "11263660"]}, {"Citation": "Reddi A. Cell Biology and Biochemistry of Endochondral Bone Development. Collagen Relat. Res. 1981;1:209\u2013226. doi: 10.1016/S0174-173X(81)80021-0.", "ArticleIdList": ["10.1016/S0174-173X(81)80021-0", "7049548"]}, {"Citation": "Jain A.P., Pundir S., Sharma A. Bone morphogenetic proteins: The anomalous molecules. J. Indian Soc. Periodontol. 2013;17:583\u2013586. doi: 10.4103/0972-124X.119275.", "ArticleIdList": ["10.4103/0972-124X.119275", "PMC3808010", "24174749"]}, {"Citation": "Davis H., Raja E., Miyazono K., Tsubakihara Y., Moustakas A. Mechanisms of action of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev. 2015;27:81\u201392. doi: 10.1016/j.cytogfr.2015.11.009.", "ArticleIdList": ["10.1016/j.cytogfr.2015.11.009", "26678814"]}, {"Citation": "Ehata S., Yokoyama Y., Takahashi K., Miyazono K. Bi-directional roles of bone morphogenetic proteins in cancer: Another molecular Jekyll and Hyde? Pathol. Int. 2013;63:287\u2013296. doi: 10.1111/pin.12067.", "ArticleIdList": ["10.1111/pin.12067", "23782330"]}, {"Citation": "Hardwick J.C., Kodach L., Offerhaus G.J., Brink G.R.V.D. Bone morphogenetic protein signalling in colorectal cancer. Nat. Cancer. 2008;8:806\u2013812. doi: 10.1038/nrc2467.", "ArticleIdList": ["10.1038/nrc2467", "18756288"]}, {"Citation": "Jaeger E., Leedham S.J., Lewis A., Segditsas S., Becker M., Cuadrado P.R., Davis H., Kaur K., Heinimann K., Howarth K., et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat. Genet. 2012;44:699\u2013703. doi: 10.1038/ng.2263.", "ArticleIdList": ["10.1038/ng.2263", "PMC4594751", "22561515"]}, {"Citation": "Skovrlj B., Koehler S.M., Anderson P.A., Qureshi S.A., Hecht A.C., Iatridis J.C., Cho S.K. Association Between BMP-2 and Carcinogenicity. Spine. 2015;40:1862\u20131871. doi: 10.1097/BRS.0000000000001126.", "ArticleIdList": ["10.1097/BRS.0000000000001126", "PMC7423158", "26274524"]}, {"Citation": "James A.W., Lachaud G., Shen J., Asatrian G., Nguyen V., Zhang X., Ting K., Soo C. A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2. Tissue Eng. Part B Rev. 2016;22:284\u2013297. doi: 10.1089/ten.teb.2015.0357.", "ArticleIdList": ["10.1089/ten.teb.2015.0357", "PMC4964756", "26857241"]}, {"Citation": "Ehata S., Miyazono K. Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years. Front. Cell Dev. Biol. 2022;10:883523. doi: 10.3389/fcell.2022.883523.", "ArticleIdList": ["10.3389/fcell.2022.883523", "PMC9174896", "35693928"]}, {"Citation": "Ma Y., Ma L., Guo Q., Zhang S. Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. J. Exp. Clin. Cancer Res. 2010;29:85\u201386. doi: 10.1186/1756-9966-29-85.", "ArticleIdList": ["10.1186/1756-9966-29-85", "PMC2907340", "20587070"]}, {"Citation": "Raida M., Clement J.H., Ameri K., Han C., Leek R.D., Harris A.L. Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death. Int. J. Oncol. 2005;26:1465\u20131470. doi: 10.3892/ijo.26.6.1465.", "ArticleIdList": ["10.3892/ijo.26.6.1465", "15870857"]}, {"Citation": "Kang M.H., Kim J.S., Seo J.E., Oh S.C., Yoo Y.A. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Exp. Cell Res. 2010;316:24\u201337. doi: 10.1016/j.yexcr.2009.10.010.", "ArticleIdList": ["10.1016/j.yexcr.2009.10.010", "19835871"]}, {"Citation": "Radadiya A., Shah A. Bioactive benzofuran derivatives: An insight on lead developments, radioligands and advances of the last decade. Eur. J. Med. Chem. 2015;5:356\u2013376. doi: 10.1016/j.ejmech.2015.01.021.", "ArticleIdList": ["10.1016/j.ejmech.2015.01.021", "25703339"]}, {"Citation": "Keri R.S., Chand K., Budagumpi S., Somappa S.B., Patil S.A., Nagaraja B.M. An overview of benzo [b] thiophene-based medicinal chemistry. Eur. J. Med. Chem. 2017;29:1002\u20131033. doi: 10.1016/j.ejmech.2017.07.038.", "ArticleIdList": ["10.1016/j.ejmech.2017.07.038", "28759875"]}, {"Citation": "Farhat J., Alzyoud L., Alwahsh M., Al-Omari B. Structure\u2013Activity Relationship of Benzofuran Derivatives with Potential Anticancer Activity. Cancers. 2022;14:2196. doi: 10.3390/cancers14092196.", "ArticleIdList": ["10.3390/cancers14092196", "PMC9099631", "35565325"]}, {"Citation": "Guo H.-F., Shao H.-Y., Yang Z.-Y., Xue S.-T., Li X., Liu Z.-Y., He X.-B., Jiang J.-D., Zhang Y.-Q., Si S.-Y., et al. Substituted Benzothiophene or Benzofuran Derivatives as a Novel Class of Bone Morphogenetic Protein-2 Up-Regulators: Synthesis, Structure\u2212Activity Relationships, and Preventive Bone Loss Efficacies in Senescence Accelerated Mice (SAMP6) and Ovariectomized Rats. J. Med. Chem. 2010;53:1819\u20131829. doi: 10.1021/jm901685n.", "ArticleIdList": ["10.1021/jm901685n", "20088515"]}, {"Citation": "Xue S.-T., Guo H.-F., Liu M.-J., Jin J., Ju D.-H., Liu Z.-Y., Li Z.-R. Synthesis of a novel class of substituted benzothiophene or benzofuran derivatives as BMP-2 up-regulators and evaluation of the BMP-2-up-regulating effects in vitro and the effects on glucocorticoid-induced osteoporosis in rats. Eur. J. Med. Chem. 2015;96:151\u2013161. doi: 10.1016/j.ejmech.2015.04.016.", "ArticleIdList": ["10.1016/j.ejmech.2015.04.016", "25874339"]}, {"Citation": "ElHady A.K., El-Gamil D.S., Chen P.J., Hwang T.L., Abadi A.H., Abdel-Halim M., Engel M. 5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency. Molecules. 2021;26:1001. doi: 10.3390/molecules26041001.", "ArticleIdList": ["10.3390/molecules26041001", "PMC7918793", "33668683"]}, {"Citation": "Eldehna W.M., Maklad R.M., Almahli H., Al-Warhi T., Elkaeed E.B., Abourehab M.A.S., Abdel-Aziz H.A., El Kerdawy A.M. Identification of 3-(piperazinylmethyl)benzofuran derivatives as novel type II CDK2 inhibitors: Design, synthesis, biological evaluation, and in silico insights. J. Enzym. Inhib. Med. Chem. 2022;37:1227\u20131240. doi: 10.1080/14756366.2022.2062337.", "ArticleIdList": ["10.1080/14756366.2022.2062337", "PMC9126595", "35470754"]}, {"Citation": "Wadood A., Jamal S.B., Riaz M., Mir A. Computational analysis of benzofuran-2-carboxlic acids as potent Pim-1 kinase inhibitors. Pharm. Biol. 2014;52:1170\u20131178. doi: 10.3109/13880209.2014.880488.", "ArticleIdList": ["10.3109/13880209.2014.880488", "24766364"]}, {"Citation": "Gao F., Wang T., Gao M., Zhang X., Liu Z., Zhao S.-J., Lv Z.-S., Xiao J. Benzofuran-isatin-imine hybrids tethered via different length alkyl linkers: Design, synthesis and in vitro evaluation of anti-tubercular and anti-bacterial activities as well as cytotoxicity. Eur. J. Med. Chem. 2019;165:323\u2013331. doi: 10.1016/j.ejmech.2019.01.042.", "ArticleIdList": ["10.1016/j.ejmech.2019.01.042", "30690301"]}, {"Citation": "Wang Z., Liu Y., Zhang J., Ullah S., Kang N., Zhao Y., Zhou H. Benzothiophene-2-carboxamide derivatives as SENPs inhibitors with selectivity within SENPs family. Eur. J. Med. Chem. 2020;204:112553. doi: 10.1016/j.ejmech.2020.112553.", "ArticleIdList": ["10.1016/j.ejmech.2020.112553", "32717481"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997;23:3\u201325. doi: 10.1016/S0169-409X(96)00423-1.", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "Veber D.F., Johnson S.R., Cheng H.-Y., Smith B.R., Ward K.W., Kopple K.D. Molecular Properties That Influence the Oral Bioavailability of Drug Candidates. J. Med. Chem. 2002;45:2615\u20132623. doi: 10.1021/jm020017n.", "ArticleIdList": ["10.1021/jm020017n", "12036371"]}, {"Citation": "El-Metwally S.A., Abou-El-Regal M.M., Eissa I.H., Mehany A.B., Mahdy H.A., Elkady H., Elwan A., Elkaeed E.B. Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. Bioorganic Chem. 2021;112:104947. doi: 10.1016/j.bioorg.2021.104947.", "ArticleIdList": ["10.1016/j.bioorg.2021.104947", "33964580"]}, {"Citation": "Alsaif N.A., Dahab M.A., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Mahdy H.A., Elkady H. New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Bioorg. Chem. 2021;110:104807. doi: 10.1016/j.bioorg.2021.104807.", "ArticleIdList": ["10.1016/j.bioorg.2021.104807", "33721808"]}, {"Citation": "Alanazi M.M., Elkady H., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Alanazi M.M., Alharbi M.A., Eissa I.H., Dahab M.A. New quinoxaline-based VEGFR-2 inhibitors: Design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. RSC Adv. 2021;11:30315\u201330328. doi: 10.1039/D1RA05925D.", "ArticleIdList": ["10.1039/D1RA05925D", "PMC9044819", "35493991"]}, {"Citation": "Abdallah A.E., Alesawy M.S., Eissa S.I., El-Fakharany E.M., Kalaba M.H., Sharaf M.H., Shama N.M.A., Mahmoud S.H., Mostafa A., Al-Karmalawy A.A., et al. Design and synthesis of new 4-(2-nitrophenoxy)benzamide derivatives as potential antiviral agents: Molecular modeling and in vitro antiviral screening. New J. Chem. 2021;45:16557\u201316571. doi: 10.1039/D1NJ02710G.", "ArticleIdList": ["10.1039/D1NJ02710G"]}, {"Citation": "Alanazi M.M., Eissa I.H., Alsaif N.A., Obaidullah A.J., Alanazi W.A., Alasmari A.F., Albassam H., Elkady H., Elwan A. Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J. Enzym. Inhib. Med. Chem. 2021;36:1760\u20131782. doi: 10.1080/14756366.2021.1956488.", "ArticleIdList": ["10.1080/14756366.2021.1956488", "PMC8344243", "34340610"]}, {"Citation": "Alsaif N.A., Taghour M.S., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Elwan A., Elkady H. Discovery of new VEGFR-2 inhibitors based on bis ([1, 2, 4] triazolo)[4, 3-a: 3\u2019, 4\u2019-c] quinoxaline derivatives as anticancer agents and apoptosis inducers. J. Enzym. Inhib. Med. Chem. 2021;36:1093\u20131114. doi: 10.1080/14756366.2021.1915303.", "ArticleIdList": ["10.1080/14756366.2021.1915303", "PMC8168755", "34056992"]}, {"Citation": "Xia X., Maliski E.G., Gallant A.P., Rogers D. Classification of Kinase Inhibitors Using a Bayesian Model. J. Med. Chem. 2004;47:4463\u20134470. doi: 10.1021/jm0303195.", "ArticleIdList": ["10.1021/jm0303195", "15317458"]}, {"Citation": "BIOVIA, QSAR, ADMET and Predictive Toxicology.  Available online:  https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html."}, {"Citation": "Molecular Operating Environment (MOE), 2014.09, Chemical Computing Group Inc., Montr\u00e9al, Canada.  Available online:  https://www.chemcomp.com."}, {"Citation": "Mehany A.B.M., Belal A., Mohamed A.F., Shaaban S., Abdelhamid G. Apoptotic and anti-angiogenic effects of propolis against human bladder cancer: Molecular docking and in vitro screening. Biomarkers. 2022;27:138\u2013150. doi: 10.1080/1354750X.2021.2020903.", "ArticleIdList": ["10.1080/1354750X.2021.2020903", "34927500"]}, {"Citation": "Belal A. 3D-Pharmacophore Modeling, Molecular Docking, and Virtual Screening for Discovery of Novel CDK4/6 Selective Inhibitors. Russ. J. Bioorg. Chem. 2021;47:317\u2013333. doi: 10.1134/S1068162021330013.", "ArticleIdList": ["10.1134/S1068162021330013"]}, {"Citation": "Zhaorigetu I.M.F., Belal A., al Badawi M.H., Abdelhady A.A., Galala F.M.A., El-Sharkawy A., El-Dahshan A.A., Mehany A.B. Antiproliferative, Apoptotic Effects and Suppression of Oxidative Stress of Quercetin against Induced Toxicity in Lung Cancer Cells of Rats: In vitro and In vivo Study. J. Cancer. 2021;12:5249. doi: 10.7150/jca.52088.", "ArticleIdList": ["10.7150/jca.52088", "PMC8317526", "34335941"]}, {"Citation": "Belal A. Pyrrolizines as Potential Anticancer Agents: Design, Synthesis, Caspase-3 activation and Micronucleus (MN) Induction. Anti-Cancer Agents Med. Chem. (Former. Curr. Med. Chem.-Anti-Cancer Agents) 2018;18:2124\u20132130. doi: 10.2174/1871520618666180409155520.", "ArticleIdList": ["10.2174/1871520618666180409155520", "29629667"]}, {"Citation": "Belal A. Synthesis, molecular docking and antitumor activity of novel pyrrolizines with potential as EGFR-TK inhibitors. Bioorg. Chem. 2015;59:124\u2013129. doi: 10.1016/j.bioorg.2015.02.006.", "ArticleIdList": ["10.1016/j.bioorg.2015.02.006", "25748126"]}, {"Citation": "El-Helby A.-G.A., Ayyad R.R., El-Adl K., Elkady H. Phthalazine-1, 4-dione derivatives as non-competitive AMPA receptor antagonists: Design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking. Mol. Divers. 2019;23:283\u2013298. doi: 10.1007/s11030-018-9871-y.", "ArticleIdList": ["10.1007/s11030-018-9871-y", "30168051"]}, {"Citation": "El-Zahabi M.A., Elbendary E.R., Bamanie F.H., Radwan M.F., Ghareib S.A., Eissa I.H. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPAR\u03b3 and SUR agonists. Bioorg. Chem. 2019;91:103115. doi: 10.1016/j.bioorg.2019.103115.", "ArticleIdList": ["10.1016/j.bioorg.2019.103115", "31310882"]}, {"Citation": "Ibrahim M.K., Eissa I.H., Alesawy M.S., Metwaly A.M., Radwan M.M., ElSohly M.A. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPAR\u03b3 and SUR agonists. Bioorg. Med. Chem. 2017;25:4723\u20134744. doi: 10.1016/j.bmc.2017.07.015.", "ArticleIdList": ["10.1016/j.bmc.2017.07.015", "28720328"]}, {"Citation": "El-Demerdash A., Metwaly A.M., Hassan A., El-Aziz A., Mohamed T., Elkaeed E.B., Eissa I.H., Arafa R.K., Stockand J.D. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19) Biomolecules. 2021;11:460. doi: 10.3390/biom11030460.", "ArticleIdList": ["10.3390/biom11030460", "PMC8003478", "33808721"]}, {"Citation": "El-Gamal K.M., El-Morsy A.M., Saad A.M., Eissa I.H., Alswah M. Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors. J. Mol. Struct. 2018;1166:15\u201333. doi: 10.1016/j.molstruc.2018.04.010.", "ArticleIdList": ["10.1016/j.molstruc.2018.04.010"]}, {"Citation": "Alanazi M.M., Mahdy H.A., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Al-Mehizia A.A., Alsubaie S.M., Dahab M.A., Eissa I.H. New bis ([1, 2, 4] triazolo)[4, 3-a: 3\u2032, 4\u2032-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation. Bioorg. Chem. 2021;112:104949. doi: 10.1016/j.bioorg.2021.104949.", "ArticleIdList": ["10.1016/j.bioorg.2021.104949", "34023640"]}, {"Citation": "Eissa I.H., El-Helby A.G.A., Mahdy H.A., Khalifa M.M., Elnagar H.A., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M., ElSohly M.A., et al. Discovery of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation. Bioorg. Chem. 2020;105:104380. doi: 10.1016/j.bioorg.2020.104380.", "ArticleIdList": ["10.1016/j.bioorg.2020.104380", "33128967"]}, {"Citation": "Eissa I.H., Dahab M.A., Ibrahim M.K., Alsaif N.A., Alanazi A., Eissa S.I., Belal A., Beauchemin A.M. Design and discovery of new antiproliferative 1, 2, 4-triazin-3 (2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site. Bioorg. Chem. 2021;112:104965. doi: 10.1016/j.bioorg.2021.104965.", "ArticleIdList": ["10.1016/j.bioorg.2021.104965", "34020238"]}, {"Citation": "Eissa I.H., Ibrahim M.K., Metwaly A.M., Belal A., Mehany A.B., Abdelhady A.A., Elhendawy M.A., Radwan M.M., ElSohly M.A., Mahdy H.A.J.B.C. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma. Bioorg. Chem. 2021;107:104532. doi: 10.1016/j.bioorg.2020.104532.", "ArticleIdList": ["10.1016/j.bioorg.2020.104532", "33334586"]}, {"Citation": "Mehany A.B.M., Belal A., Santali E.Y., Shaaban S., Abourehab M.A.S., El-Feky O.A., Diab M., Galala F.M.A.A., Elkaeed E.B., Abdelhamid G. Biological Effect of Quercetin in Repairing Brain Damage and Cerebral Changes in Rats: Molecular Docking and In Vivo Studies. BioMed Res. Int. 2022;2022:1\u201312. doi: 10.1155/2022/8962149.", "ArticleIdList": ["10.1155/2022/8962149", "PMC9071882", "35528172"]}, {"Citation": "Belal A., Elanany M.A., Raafat M., Hamza H.T., Mehany A.B.M. Calendula officinalis Phytochemicals for the Treatment of Wounds Through Matrix Metalloproteinases-8 and 9 (MMP-8 and MMP-9): In Silico Approach. Nat. Prod. Commun. 2022;17:1934578X221098848. doi: 10.1177/1934578X221098848.", "ArticleIdList": ["10.1177/1934578X221098848"]}, {"Citation": "Sun X., Belal A., Elanany M.A., Alsantali R.I., Alrooqi M.M., Mohamed A.R., Hasabelnaby S. Identification of Some Promising Heterocycles Useful in Treatment of Allergic Rhinitis: Virtual Screening, Pharmacophore Mapping, Molecular Docking, and Molecular Dynamics. Russ. J. Bioorg. Chem. 2022;48:438\u2013456.", "ArticleIdList": ["PMC9134989", "35637779"]}, {"Citation": "Belal A., Gawad N.M.A., Mehany A.B.M., Abourehab M.A.S., Elkady H., Al-Karmalawy A.A., Ismael A.S. Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine de-rivatives as potent EGFR/CDK2 inhibitors. J. Enzym. Inhib. Med. Chem. 2022;37:1884\u20131902. doi: 10.1080/14756366.2022.2096019.", "ArticleIdList": ["10.1080/14756366.2022.2096019", "PMC9272933", "35801486"]}, {"Citation": "Elkaeed E.B., Elkady H., Belal A., Alsfouk B.A., Ibrahim T.H., Abdelmoaty M., Arafa R.K., Metwaly A.M., Eissa H.I. Mul-ti-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs. Processes. 2022;10:530. doi: 10.3390/pr10030530.", "ArticleIdList": ["10.3390/pr10030530"]}, {"Citation": "El-Naggar A.M., Eissa I.H., Belal A., El-Sayed A.A. Design, eco-friendly synthesis, molecular modeling and anticancer eval-uation of thiazol-5 (4 H)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding site. RSC Adv. 2020;10:2791\u20132811. doi: 10.1039/C9RA10094F.", "ArticleIdList": ["10.1039/C9RA10094F", "PMC9048505", "35496078"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "7", "Day": "15"}, {"Year": "2022", "Month": "8", "Day": "13"}, {"Year": "2022", "Month": "8", "Day": "18"}, {"Year": "2022", "Month": "9", "Day": "9", "Hour": "1", "Minute": "28"}, {"Year": "2022", "Month": "9", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "8", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["36080338", "PMC9457949", "10.3390/molecules27175571", "molecules27175571"]}}], "PubmedBookArticle": []}